News from saladax biomedical, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Mar 20, 2014, 06:05 ET A Dose of Reality About Chemotherapy Dosing -- Saladax Has The Antidote - My5-FU™

Saladax Biomedical, Inc. announced today that Saladax Biomedical Laboratories is offering a simple blood test for the personalization and...

Jun 19, 2013, 09:00 ET Saladax Biomedical Announces U.S. Launch of MyCare™ Portfolio of Chemotherapy Exposure Optimization Tests

Saladax Biomedical, Inc., a privately held company developing novel diagnostic tests that help physicians to optimize a patient's exposure to...

Jun 10, 2013, 09:01 ET Saladax Receives CLIA Laboratory Certification and Approval to Begin Clinical Laboratory Operations in Support of MyCare™ Portfolio

Saladax Biomedical, Inc., a privately held company developing novel diagnostic tests that individually optimize a patient's exposure to chemotherapy, ...

Apr 18, 2013, 08:30 ET Saladax Recruits Top Talent as Commercial Introduction of MyCare™ Portfolio of Oncology Diagnostics Nears

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Mar 05, 2013, 03:02 ET Saladax Biomedical Receives $22.4 Million Strategic Equity Investment From Shanghai Fosun Pharmaceutical

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Feb 11, 2013, 10:17 ET Saladax Biomedical Laboratories to Offer the Full Portfolio of MyCare™ Therapeutic Dose Management Assays in the United States

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Dec 06, 2012, 10:17 ET Saladax Biomedical, Inc. Announces the Formation of a CLIA Laboratory As Part of the Company's Commercialization Strategy

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Nov 16, 2012, 10:17 ET Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Sep 12, 2012, 10:17 ET Saladax Biomedical, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York City

Saladax Biomedical, Inc., a commercial-stage, companion diagnostic company with an existing pipeline that enables personalized medicine, announced...

Sep 05, 2012, 10:17 ET Saladax Biomedical, Inc. Expands Distribution of MyCare™ Products in Israel

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Aug 06, 2012, 10:17 ET Saladax Biomedical Enters into Master Collaboration Agreement with Bristol-Myers Squibb

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Jul 09, 2012, 10:17 ET Saladax Biomedical, Inc. Extends Availability of its MyCare™ Portfolio in Europe

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Jun 15, 2012, 10:17 ET Saladax Biomedical, Inc. Appoints Kevin M. Harter as President and Chief Executive Officer

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Apr 23, 2012, 10:17 ET Saladax Biomedical, Inc. Expands Distribution of My5-FU in Egypt and Throughout the Middle East North African (MENA) Region

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Mar 12, 2012, 10:17 ET Saladax Biomedical, Inc. Expands Distribution of My5-FU in Spain and Portugal

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Feb 13, 2012, 10:17 ET CESAR and Saladax Biomedical Collaborate on a Study of Optimized 5-FU Dosing in Colorectal Cancer Patients

Saladax Biomedical, Inc. and the Central European Society for Anticancer Drug Research (CESAR) announced today they will be collaborating in a single ...

Jan 27, 2012, 01:33 ET Saladax Biomedical, Inc. Announces the Resignation of Edward L. Erickson as President and Chief Executive Officer

Saladax Biomedical, Inc., a privately-held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Jan 10, 2012, 10:17 ET Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Jan 04, 2012, 04:26 ET Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Dec 16, 2011, 10:17 ET Saladax Biomedical, Inc. Expands Distribution of My5-FU in Europe

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Nov 01, 2011, 10:17 ET Saladax Biomedical, Inc. Names Edward Chu, M.D., Chair of the Company's Scientific Advisory Board

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Sep 13, 2011, 10:17 ET Saladax Biomedical, Inc. to Present at the Annual UBS Global Life Sciences Conference in New York City

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Aug 08, 2011, 10:17 ET Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Jul 06, 2011, 10:17 ET Saladax Biomedical, Inc. Announces Appointment of Gregory C. Critchfield, M.D., M.S. as Chairman of the Company's Board of Directors

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...

Jun 21, 2011, 08:02 ET Saladax Biomedical, Inc. Completes $9 Million Debt Financing With GE Capital

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized...